←Back to Expert Scholars
Translational Medicine / 转化医学Allogeneic HCT, Myeloma and Conditioning
Sergio Giralt
MD
🏢Memorial Sloan Kettering Cancer Center🌐USA
Deputy Head, Division of Hematologic Malignancies
120
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Sergio Giralt has led reduced-intensity conditioning development and myeloma transplant trials over three decades. He has directed large HCT programs and served in ASBMT leadership roles. His research shapes older-patient transplant eligibility.
Share:
🧪Research Fields 研究领域
myeloma transplant
reduced intensity conditioning
allogeneic HCT
autologous HCT
clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Sergio Giralt 的研究动态
Follow Sergio Giralt's research updates
留下邮箱，当我们发布与 Sergio Giralt（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment